FILTER
FILTERED INTERVIEW RESULTS
Louis Watum
PRESIDENT OF THE CHAMBER OF MINES, DRC
The Chamber of Mines of the DRC explains the conditions relating to the mining industry there.
Stephen Smithyman
CEO, KANU EQUIPMENT
Kanu Equipment comments on the challenges and opportunities in Africa for a mining and construction dealership.
Luke Alexander
PRESIDENT, CEO AND DIRECTOR, NEWCORE GOLD LTD.
Newcore Gold enthuses about the prospects of its major drilling campaign at its Enchi gold project in Ghana.
Liam Morrissey
CEO, MS RISK
MS Risk speaks of the danger that the war in the Sahel represents to mines and businesses.
Simon Meadows Smith
MANAGING DIRECTOR, SEMS EXPLORATION SERVICES
SEMS Exploration is a consultancy and exploration services company in West Africa. Geologist and Managing Director, Simon Meadows Smith, walks us through the trends he observes in the region.
John Gladston
GOVERNMENT AFFAIRS MANAGER, FIRST QUANTUM MINERALS LIMITED (FIRST QUANTUM)
First Quantum comments on the performance of its Zambian copper assets during 2020.
George Kwatia
PARTNER, PWC GHANA
PwC Ghana comments on how the mining industry and the Ghanian government are managing the impacts of the pandemic.
Osam Iyahen
SENIOR DIRECTOR NATURAL RESOURCES, AFRICA FINANCE CORPORATION
Africa Finance Corporation explains its role of investing in infrastructure across Africa in order to both assist and benefit from the growth that this will engender.
Will Coetzer & Jane Banks
MANAGING PARTNER & PRINCIPAL CONSULTANT, STRATUM INTERNATIONAL
Stratum International explains the shifts in the mining industry recruitment patterns.
John Kwofie & Ivan Doku
PRINCIPAL MINING ENGINEER AND COUNTRY MANAGER & PRINCIPAL RESOURCE GEOLOGIST AND COUNTRY MANAGER-DESIGNATE, SRK CONSULTING
An overview of the firm’s activities in West Africa.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
